FDA Inspection 1288500 — Bioreliance Ltd.
The FDA completed an inspection of Bioreliance Ltd. on December 5, 2025 in Glasgow. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 5, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Glasgow (United Kingdom)